AIM ImmunoTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Revenue	0.2	0.14	0.14	0.16	0.14	0.37	0.44	0.09	0.13	0.2	Upgrade
Revenue Growth (YoY)	43.26%	4.44%	-17.18%	16.43%	-61.85%	-16.02%	375.00%	-30.83%	-32.49%	31.33%	Upgrade
Cost of Revenue	0.04	0	0.85	0.81	0.89	0.88	1.18	1.11	1.6	1.25	Upgrade
Gross Profit	0.16	0.14	-0.72	-0.64	-0.75	-0.52	-0.75	-1.02	-1.47	-1.05	Upgrade
Selling, General & Admin	21.14	13.07	8.67	8.65	7.04	6.2	6.57	7.68	7.15	9.06	Upgrade
Research & Development	10.94	6.99	7.67	5.72	4.65	4.78	4.1	5.11	8.04	8.99	Upgrade
Other Operating Expenses	-0.02	-0	1.56	0.14	0	-0.22	0	-1.63	0	0	Upgrade
Operating Expenses	32.06	20.06	17.91	14.51	11.69	10.76	10.67	11.16	15.19	18.05	Upgrade
Operating Income	-31.9	-19.92	-18.62	-15.15	-12.44	-11.27	-11.42	-12.18	-16.65	-19.1	Upgrade
Interest Expense / Income	0	0	0.07	0.67	0.43	0.5	0.14	0	0	0.01	Upgrade
Other Expense / Income	-2.94	-0.48	0.44	-1.42	-3.47	-1.95	-3.3	-4.68	-1.42	-1.66	Upgrade
Pretax Income	-28.96	-19.45	-19.13	-14.4	-9.4	-9.83	-8.26	-7.5	-15.23	-17.45	Upgrade
Net Income	-28.96	-19.45	-19.13	-14.4	-9.4	-9.83	-8.26	-7.5	-15.23	-17.45	Upgrade
Shares Outstanding (Basic)	49	48	47	32	4	1	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	49	48	47	32	4	1	1	0	0	0	Upgrade
Shares Change	1.12%	1.49%	48.67%	774.15%	262.71%	54.10%	31.43%	10.87%	25.42%	12.53%	Upgrade
EPS (Basic)	-0.60	-0.40	-0.40	-0.45	-2.58	-9.77	-12.76	-14.96	-33.88	-48.84	Upgrade
EPS (Diluted)	-0.60	-0.40	-0.40	-0.45	-2.58	-9.77	-12.76	-14.96	-33.88	-48.84	Upgrade
Free Cash Flow	-21.22	-12.29	-13.76	-10.39	-9.14	-9.64	-8.01	-7.83	-16.54	-14.73	Upgrade
Free Cash Flow Per Share	-0.44	-0.26	-0.29	-0.33	-2.51	-9.60	-12.29	-15.80	-36.99	-41.29	Upgrade
Gross Margin	79.21%	100.00%	-529.63%	-394.48%	-537.86%	-140.87%	-170.71%	-1104.35%	-1101.50%	-535.03%	Upgrade
Operating Margin	-15791.09%	-14127.66%	-13794.07%	-9295.71%	-8887.86%	-3071.66%	-2612.36%	-13236.96%	-12518.80%	-9694.92%	Upgrade
Profit Margin	-14337.62%	-13790.78%	-14168.15%	-8834.36%	-6717.14%	-2677.66%	-1889.93%	-8154.35%	-11451.13%	-8857.87%	Upgrade
Free Cash Flow Margin	-10504.95%	-8719.15%	-10193.33%	-6374.23%	-6525.00%	-2626.98%	-1832.95%	-8515.22%	-12438.35%	-7475.13%	Upgrade
EBITDA	-28.44	-19.87	-18.29	-13	-8.19	-8.45	-7.17	-6.38	-14.29	-16.77	Upgrade
EBITDA Margin	-14077.72%	-14091.49%	-13544.44%	-7972.39%	-5846.43%	-2301.63%	-1641.19%	-6938.04%	-10741.35%	-8514.72%	Upgrade
Depreciation & Amortization	0.53	-0.42	0.78	0.73	0.79	0.88	0.95	1.12	0.94	0.67	Upgrade
EBIT	-28.96	-19.45	-19.06	-13.73	-8.98	-9.33	-8.12	-7.5	-15.23	-17.44	Upgrade
EBIT Margin	-14337.62%	-13790.78%	-14118.52%	-8422.09%	-6412.14%	-2540.87%	-1858.12%	-8154.35%	-11448.87%	-8852.28%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).